Triple
T33292570
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bortecad |
E852352
|
entity |
| Predicate | indicatedForLineOfTherapy |
P97066
|
FINISHED |
| Object | first-line treatment of multiple myeloma in combination regimens |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: first-line treatment of multiple myeloma in combination regimens | Statement: [Bortecad, indicatedForLineOfTherapy, first-line treatment of multiple myeloma in combination regimens]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: indicatedForLineOfTherapy Context triple: [Bortecad, indicatedForLineOfTherapy, first-line treatment of multiple myeloma in combination regimens]
-
A.
treatmentIndication
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
B.
indicatedFor
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
-
C.
therapyLine
chosen
Indicates that one entity is a specific therapeutic product, regimen, or line of treatment used in the medical management of another entity.
-
D.
isIndicatedAsMonotherapyFor
Indicates that a treatment is recommended or used alone, without combination with other therapies, for a particular condition or purpose.
-
E.
isTumorAgnostic
Indicates that a treatment, biomarker, or effect applies across multiple tumor types regardless of the cancer’s tissue or organ of origin.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f349660ff48190a4568803d0b89941 |
completed | April 30, 2026, 12:21 p.m. |
| NER | Named-entity recognition | batch_69f6e3156ea48190b604e414665ef351 |
completed | May 3, 2026, 5:54 a.m. |
| PD | Predicate disambiguation | batch_69f6de0b9ba48190887c9eb5d06a2e94 |
completed | May 3, 2026, 5:32 a.m. |
Created at: May 1, 2026, 1:33 a.m.